Special Issue "Flavivirus Vaccines"
Deadline for manuscript submissions: 21 October 2020.
Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore
Pathology Department, SingHealth Duke-NUS Global Health Institute, Singapore 168753, Singapore
Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
Flaviviruses consist of diverse group of pathogens responsible for hundreds of millions of human infections annually. While there are highly effective vaccines to certain flaviviruses, such as Yellow Fever Virus, other Flavivirus vaccines are largely in developmental stages. Many factors may govern natural infection clearance or vaccine effectiveness, including but not limited to the initiation of immune responses at the site of infection, the time between exposures to vaccines or natural infections, and the vaccine composition. Due to their close antigenic relationships, flaviviruses evoke immune responses that are cross-reactive, and this presents complex challenges for vaccine development. These cross-reactive immune responses could potentially be pathogenic or may provide Flavivirus cross-protection. In this Special Issue, we will highlight advances in Flavivirus vaccine development and in the understanding of host immune responses that can inform vaccine design. We also welcome research that will broaden our understanding of Flavivirus cross-reactive immune responses.
Dr. Ashley L. St. John
Dr. Abhay P.S. Rathore
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Mosquito borne flaviviruses including Dengue, Zika, West Nile, Kunjin, Usutu, Ntaya, Japanese encephalitis, Yellow fever, and more
- Tick-borne flaviviruses including but not limited to Omsk hemorrhagic fever, Powassan, and Kyasanur forest disease
- Vaccines and vaccine platforms
- Adaptive immunity and Immune memory (T and B cell responses)
- Flavivirus cross-reactive immune responses
- Skin immunity
- Host–virus protein interactions that may influence vaccine effectiveness